MasterSwitch Bio
Ambler
About MasterSwitch Bio
MasterSwitch Bio is a promising novel company that aims to treat end stage liver disease (ESLD) with cirrhosis from various disease.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 1 – 10
- Total funding: $250.0K
- Funding stage: Seed
- Last round: Pre-Seed (Jun 2025)
Canonical: https://fsome.com/organization/masterswitch-bio-173728 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.